Spirometer is a device used for measurement of lung capacity by measuring the amount of air that goes in and out of the lungs while breathing. In a spirometer test, the patient takes a deep breath into the spirometer tube which is attached to a reader for measurement and recording of air capacity of the lungs. Any deviation from the normal values of spirometer reading indicates malfunctioning of the lungs. Spirometer can be used for diagnosis of chronic pulmonary diseases such as cystic fibrosis, pulmonary fibrosis, emphysema, chronic bronchitis, asthma, bronchiectasis, and others. A spirometer can also aid in practicing breathing exercises in case of chronic pulmonary diseases and prevent accumulation of mucus and fluid inside the lungs. Additionally, a spirometer can also be used to assess lung function prior to a surgery such as bariatric surgery, knee replacement surgery, and others.
The global spirometer market is estimated to be valued at US$ 958.0 million in 2021 and is expected to exhibit a CAGR of 9.5% over the forecast period (2021-2028).
Figure 1. Global Spirometer Market Share (%), By Region, 2021
The increasing prevalence of chronic respiratory disorders such as asthma, pulmonary fibrosis, emphysema, and others is expected to drive the growth of the global spirometer market over the forecast period.
For instance, according to asthma facts and statistics provided by the Asthma U.K. and British Lung Foundation Partnership, in 2017 around 5.4 million people in the U.K received treatment for asthma while three people die of asthma every day in the U.K. The same source states that around 77,124 people in the U.K. were admitted to hospital for asthma during 2017.
Moreover, according to the data provided by the Centers for Disease Control and Prevention in 2018, it has been observed that the prevalence of asthma in the U.S. has increased from 7.3% in 2001 to 7.9% in 2017.
| Report Coverage | Details | ||
|---|---|---|---|
| Base Year: | 2020 | Market Size in 2021: | US$ 958.0 Mn |
| Historical Data for: | 2017 to 2020 | Forecast Period: | 2021 to 2028 |
| Forecast Period 2021 to 2028 CAGR: | 9.5% | 2028 Value Projection: | US$ 1,808.3 Mn |
| Geographies covered: |
|
||
| Segments covered: |
|
||
| Companies covered: |
Koninklijke Philips N.V., SCHILLER, Midmark Corporation, Smiths Medical, Vyaire Medical, Inc., SDI Diagnostics, Nihon Kohden Corporation, COSMED srl, Fukuda Sangyo Co. Ltd., Medicare Systems, MGC Diagnostics Corporation, LabTech, Vitalograph, Futuremed, Geratherm Medical AG, Guangzhou Medsinglong Medical Equipment Co., Ltd, and Welch Allyn |
||
| Growth Drivers: |
|
||
| Restraints & Challenges: |
|
||
Figure 2. Global Spirometer Market Value (US$ Mn), By Application, 2021
The increasing research and development activities for the development of technologically advanced spirometer is expected to drive the market growth over the forecast period.
For instance, in September 2019 a phase III clinical trial study was completed by the University of Illinois at Chicago in collaboration with Agency for Healthcare Research and Quality, an agency belonging to the U.S. Department of Health and Human Services. This clinical trial indicates that the use of spirometer can aid in identifying diagnostic error in patients suffering from chronic obstructive pulmonary disease and asthma.
The market players are focusing on product launches and regulatory approvals for their products which is expected to drive the market growth over the forecast period.
For instance, in June 2018, Henry Schein, Inc., a U.S. based distributor of healthcare products and services launched its new Henry Schein EasyOne Air spirometer which aids in accurate diagnosis of chronic obstructive pulmonary disease.
Global Spirometer Market – Impact of Coronavirus (Covid-19) Pandemic
Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19, as pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 197,788,117 cases and 4,219,578 deaths due to Coronavirus (COVID-19) were reported till August 3, 2021, across the globe.
The COVID-19 pandemic and lockdown in various countries across the globe has negatively impacted the financial status of businesses across all sectors. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry mainly due to strict lockdown in several regions. However, COVID-19 pandemic is expected to have a positive impact on spirometer market in this COVID-19 pandemic owing to need for methods which could be used to provide relief from breathing problems faced by COVID-19 patients.
For instance, according to a research article published by the American Journal of Emergency Medicine in January 2021, researchers at University of Illinois at Chicago have proposed the usage of incentive spirometry for treatment of COVID-19 patients suffering from mild to moderate respiratory symptoms by helping in expansion of lung capacity. Incentive spirometry is usually used in patients suffering from chronic obstructive pulmonary disease exacerbations, pneumonia, acute chest syndrome, and other similar respiratory disorders.
Global Spirometer Market - Restraint
The lack of awareness about symptoms of respiratory disorders in low income countries such as Africa, Bangladesh, Benin, and others, and irregularities in spirometer readings due to human error are the factors that are expected to hinder growth of the global spirometer market over the forecast period.
Key Players
Major players operating in the global spirometer market include Koninklijke Philips N.V., SCHILLER, Midmark Corporation, Smiths Medical, Vyaire Medical, Inc., SDI Diagnostics, Nihon Kohden Corporation, COSMED srl, Fukuda Sangyo Co. Ltd., Medicare Systems, MGC Diagnostics Corporation, LabTech, Vitalograph, Futuremed, Geratherm Medical AG, Guangzhou Medsinglong Medical Equipment Co., Ltd, and Welch Allyn
Spirometer is a non-invasive medical device which is used to assess the functioning of lungs by measuring the amount of air inhaled and exhaled. Spirometer is a commonly used device for diagnosis of respiratory disorders such as chronic obstructive pulmonary disease (COPD), asthma, and others. Spirometer may also be used to monitor the progress of a treatment for chronic lung disease in order to determine if a treatment is effective in helping the patient to breathe better. A spirometer is based on the measurement of two key factors: forced expiratory volume (FEV) and forced vital capacity (FVC). Forced expiratory volume can be defined as the air volume that can be forced out of the lungs in a second. Forced vital capacity is referred to as the largest volume of air that can be forced out of the lungs after a deep breath. FVC and FEV reading helps a physician to assess the severity of breathing problems faced by the patient. When the FVC reading is lower than the normal reading, it is indicative of restricted breathing while a lower FEV reading indicates severe obstruction in breathing.
Market Dynamics
The increasing prevalence of respiratory disorders, rising automation in the field of healthcare, and increasing adoption of inorganic growth strategies such as acquisitions, mergers, collaborations, and others by key players operating in the market, are the major factors that are expected to drive growth of the global spirometer market over the forecast period.
For instance, according to the statistics provided by the World Health Organization (WHO), in 2019 around 262 million people suffered from asthma globally, thus making asthma one of the major non-communicable disease which can affect both adults as well as children.
Key features of the study:
Detailed Segmentation:
“*” marked represents similar segmentation in other categories in the respective section.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients